Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice (Q44682623)

5 December 2017

Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice (English)

1 reference

5 December 2017

3

Pascale Jolliet

1 reference

5 December 2017

4

Michel Bourin

1 reference

5 December 2017

2

Martine Hascoët

1 reference

PubMed ID

14659583

Bríd Aine Nic Dhonnchadha

5 December 2017

series ordinal

1

object named as

Bríd Aine Nic Dhonnchadha

1 reference

PubMed ID

14659583

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Behavioural Brain Research

5 December 2017

1 reference

5 December 2017

147

1 reference

5 December 2017

175-184

1 reference

5 December 2017

1-2

1 reference

5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex.

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Evaluation of a rapid technique for detecting minor tranquilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Absorption and brain penetration of a high affinity, highly selective 5-HT2C receptor antagonist, RS-102221.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Molecular, pharmacological and functional diversity of 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Pharmacological characterisation of human 5-HT2 receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Chronic electroconvulsive shock decreases (+/-) 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride (DOI)-induced wet-dog shake behaviors of dexamethasone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

A multiple-test study of anxiety-related behaviours in six inbred rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

The concept of selectivity in 5-HT receptor research

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900179-7

7 January 2021

10.1016/S0166-4328(03)00179-7

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14659583